Mack Gene Insider Trades

Insider Trading History

Track insider trading activity for Mack Gene. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gain Therapeutics
Gain Therapeutics GANX
Ceo, President
Holding Value $372k 200,000 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$372k 200,000 shares
$1.86
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Ceo, President
Holding Value $372k 200,000 shares
Last Trade
Mar 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$458k 200,000 shares
$2.29
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Ceo, President
Holding Value $505k 271,325 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662k 271,325 shares
$2.44
$1.86
Gain Therapeutics
Gain Therapeutics GANX
CFO And Interim CEO
Holding Value $26.8k 14,400 shares
Last Trade
Aug 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.5k 14,400 shares
$1.01
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Chief Financial Officer
Holding Value $372k 200,000 shares
Last Trade
Apr 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$712k 200,000 shares
$3.56
$1.86
SELLAS Life Sciences Group
SELLAS Life Sciences Group SLS
CFO And Treasurer
Holding Value $362k 40,000 shares
Last Trade
Apr 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8M 40,000 shares
$269.00
$9.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up